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In eukaryotes, the C-terminal domain (CTD) of Rpb1 contains a heptapeptide repeat sequence of (Y1S2P3T4S5P6S7)n that under-
goes reversible phosphorylation through the opposing action of kinases and phosphatases. Rtr1 is a conserved protein that colo-
calizes with RNA polymerase II (RNAPII) and has been shown to be important for the transition from elongation to termination
during transcription by removing RNAPII CTD serine 5 phosphorylation (Ser5-P) at a selection of target genes. In this study, we
show that Rtr1 is a global regulator of the CTD code with deletion of RTR1 causing genome-wide changes in Ser5-P CTD phos-
phorylation and cotranscriptional histone H3 lysine 36 trimethylation (H3K36me3). Using chromatin immunoprecipitation and
high-resolutionmicroarrays, we show that RTR1 deletion results in global changes in RNAPII Ser5-P levels on genes with differ-
ent lengths and transcription rates consistent with its role as a CTD phosphatase. Although Ser5-P levels increase, the overall
occupancy of RNAPII either decreases or stays the same in the absence of RTR1. Additionally, the loss of Rtr1 in vivo leads to
increases in H3K36me3 levels genome-wide, while total histone H3 levels remain relatively constant within coding regions.
Overall, these findings suggest that Rtr1 regulates H3K36me3 levels through changes in the number of binding sites for the his-
tone methyltransferase Set2, thereby influencing both the CTD and histone codes.
Reversible phosphorylation of the C-terminal domain (CTD)of the largest subunit of RNA polymerase II (RNAPII) con-
trols transcription elongation and termination through the or-
derly recruitment of transcription regulatory factors. These fac-
tors are involved in various processes includingmRNAprocessing
and cotranscriptional histone modifications (1–3). The CTD is
comprised of the heptapeptide repeat of Y1S2P3T4S5P6S7 that is
highly conserved with 26 repeats in Saccharomyces cerevisiae, 42
repeats inDrosophila melanogaster, and 52 repeats in humans and
is essential for viability (4–10). The CTD is an unstructured do-
main that is unique to RNAPII and contains some degenerative
repeats that deviate from the canonical sequence (11). Multiple
residues within the CTD repeats are phosphorylated (P) at differ-
ent stages of the transcription cycle; these residues include Ser2,
Ser5, Ser7, Tyr1, and Tyr4, which thereby serve as a signaling
scaffold for RNAPII transcriptionmachinery (12). The phosphor-
ylation of Ser2, Ser5, and Ser7 in S. cerevisiae has been well char-
acterized by several laboratories (13, 14). Phosphorylation of Tyr1
and Thr4 are less characterized but have also been implicated in
the regulation of RNAPII transcription (12, 15). Additionally, the
proline at position six in the CTD repeats is subject to cis-trans
isomerization by Ess1 (16, 17).Despite a great deal of research into
these modifications, the extent to which these modifications co-
exist in a phosphorylated and nonphosphorylated state on a single
heptapeptide repeat in vivo remains enigmatic.
The reversible phosphorylation of the CTD through the action
of kinases and phosphatases generates a “CTD code” that has been
shown to correlate with RNAPII location on the gene (13, 18–20).
At the beginning of transcription, RNAPII is in a hypophosphor-
ylated state as it is recruited to the preinitiation complex at the
promoter of a target gene (21). Promoter escape correlates with a
rise in the levels of Ser5 and Ser7 phosphorylation (Ser5-P and
Ser7-P, respectively), which aremodified through the action of the
transcription factor IIH (TFIIH) subunit Kin28 (14, 18, 19, 22,
23). Once RNAPII enters into productive transcript elongation,
Ser5-P levels decrease while Ser7-P and Ser2-P levels continue to
accumulate (13, 19). These two modifications are significant for
the recruitment of factors involved in transcription elongation,
termination, and 3=-end processing (24–26). Chromatin immu-
noprecipitation (ChIP) studies investigating Ser5-P using theH14
antibody (shown to detect CTD sequences phosphorylated at both
Ser5 and Ser2 [27]) suggest that Ser5 is dephosphorylated within
the first few hundred base pairs of transcription elongation at a
small number of RNAPII target genes (22). However, a more-
recent global study with the 3E8 antibody found that Ser5-P levels
begin to decrease within 500 bp after the transcription start site
(TSS), but approximately half of the detectable signal remains
throughout the gene body (18). Concurrent with Ser5 dephos-
phorylation, Ser2-P increases through the action of the kinase
complex CTDK-I and remains phosphorylated through the tran-
scription termination site (TTS), during which this modification
has been shown to recruit transcription termination factors (25,
28). The phosphatase Fcp1 removes the Ser2-P mark at the end of
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transcription, thereby making hypophosphorylated RNAPII
available for a subsequent round of transcription (29, 30).
The transition of RNAPII from Ser5-P to Ser2-P is an impor-
tant step in the transcription cycle and is regulated by multiple
layers of regulation. The dual-specificity phosphatase family
member Ssu72 has been shown to remove Ser5-P from the CTD
(31). Interestingly, Ssu72 localizes primarily at the 3= end of the
gene as a subunit of the cleavage and polyadenylation factor
(CPF) and is involved in mRNA processing events and control
of RNAPII termination (32–36). Ssu72 also participates in gene
looping and the suppression of divergent transcription (37, 38).
Rtr1 is a conserved protein that has been reported by both in vitro
and in vivo experimental studies to be a phosphatase responsible
for the removal of Ser5-P from the CTD (14, 39–42). ChIP assays
found that the localization of Rtr1 is predominant between the
peaks of Ser5-P and Ser2-P. Analysis of RNAPII in RTR1 deletion
cells found that Ser5-P RNAPII accumulates in whole-cell extracts
in the absence of Rtr1 activity (39). In addition, the human ho-
mologue of Rtr1, RPAP2, also displays phosphatase activity that is
specific for Ser5-P (40, 43). Overall, these studies have implicated
both Ssu72 and Rtr1 in the removal of Ser5-P during the RNAPII
transcription cycle.
Set2 is a histone lysine methyltransferase that modifies coding
region histones on histone H3 at K36 and is the sole histone H3
lysine 36 (H3K36) methyltransferase in Saccharomyces cerevisiae.
Set2 has been shown to interact with the Ser2 and Ser5 diphos-
phorylated form of transcribing RNAPII through the Set2-Rpb1-
interacting (SRI) domain in a Ctk1-dependent manner (44–48).
We have previously found that the Rtr1 interaction with RNAPII
is dependent on Ctk1 activity and that Rtr1 can interact with
RNAPII phosphorylated at Ser2, Ser5, and/or Ser7 (49). In fact,
multiple lines of evidence suggest that Rtr1 binds to a multiply
phosphorylated form of the RNAPII CTD (40–42, 49). These data
suggest that Rtr1 can act as both a reader and an eraser for theCTD
code and could function as a potential regulator of Set2 targeting
to RNAPII target genes through regulation of Ser5-P RNAPII lev-
els. The recruitment of Set2 by Ser2 and Ser5 CTD phosphoryla-
tion directs H3K36 methylation across transcribed RNAPII genes
(47, 50). However, the role of Rtr1-dependent Ser5-P CTD de-
phosphorylation in Set2 recruitment and histone H3K36 methyl-
ation has not been investigated.
In this study, we show that S. cerevisiae Rtr1 is a regulator of
Ser5 phosphorylation in the RNAPII CTD in agreement with pre-
vious findings (14, 39, 41, 49, 51, 52). We show that deletion of
RTR1 leads to global increases in Ser5-P CTD occupancy at
RNAPII target genes, suggesting that Rtr1 is a general regulator
of RNAPII phosphorylation during transcription elongation.
Chromatin immunoprecipitation experiments in an RTR1 dele-
tion strain (rtr1) show global accumulation of Ser5-P RNAPII
primarily at the 3= ends of target genes regardless of gene length.
This finding is specific for Rtr1, since the RTR2 deletion strain
(rtr2) does not appear to affect Ser5-P levels at PMA1. Further-
more, we provide genome-wide evidence that Rtr1 activity regu-
lates H3K36 trimethylation (H3K36me3) levels across RNAPII
target genes. Overall, this study clearly shows that Rtr1 is an im-
portant global regulator of the CTD code during RNAPII tran-
scription elongation. Changes in Rtr1-mediated dephosphoryla-
tion of RNAPII lead to increased Ser5-P levels at the 3= ends of
mRNA-encoding genes, which causes a coordinate increase in his-
tone H3K36me3 levels within the coding region.
MATERIALS AND METHODS
Chromatin immunoprecipitation. For a detailed description of chroma-
tin immunoprecipitation, seeMosley et al. (39) and Fox et al. (53). Briefly,
200-ml cultures were grown at 30°C until they reached an optical density
at 600 nm (OD600) of 0.8 to 1.0. The cultures were cross-linked with
formaldehyde (1% vol/vol) for 15 min, and the reaction was quenched by
adding glycine to a final concentration of 125 mM. The cells were spun
down, washed, and stored at80°C. The cells were thawed and lysed by
bead beating. The chromatin pellet was sonicated to yield fragments be-
tween 200 and 500 bp using a Branson 450 instrument (at a setting of 4,
duty cycle 90%, 12 pulses for 7 cycles) while cooling samples on ice be-
tween cycles. Following an overnight incubation with the H14 antibody
against Ser5-P RNAPII (Covance), a histone H3 lysine 36 trimethylation
antibody (Abcam) or an antibody directed against the C terminus of his-
tone H3 (Abcam) was used. The antibodies were subsequently pulled
downusing proteinG-Sepharose. The beadswerewashed extensively, and
DNA was eluted as previously described.
Chromatin immunoprecipitation with microarray technology
(ChIP-chip) sample preparation and hybridization. Amass of 5 g Cy-
labeled samples with specific activity of greater than 15 pmol/g were
combined for each channel and hybridized according to the Agilent Yeast
ChIP-on-chip Analysis Protocol (54). Hybridization occurred in an Agilent
rotisserie hybridization oven set at 20 rpm and 65°C for 40 h.
ChIP-chip data analysis. Agilent feature text files were read into R
(3.1.2) using the limma package (3.22.1). Data were normalized within
arrays using median normalization. Each gene in the yeast genome was
divided into six equally sized bins. Five hundred base pairs of the up-
stream and downstream intergenic regions were divided into two bins on
each side of the gene. The normalized average microarray log2 (immuno-
precipitated [IP]/input) value for each probe was assigned to the closest
bin (whichever bin midpoint was closest to the probe midpoint). In this
way, a matrix was generated with 10 columns and a row for each gene in
the yeast genome. Each column was then averaged and plotted to display
average expression over the gene region. Clustering was performed as
previously described by k-means clustering using the multiexperiment
viewer, part of the TM4 microarray software suite (55, 56).
GO term analysis. GOstat analysis was performed to determine sig-
nificantly overrepresented genes from our five clusters (57). The 7,112
yeast genes, divided into their respective clusters, were entered into the
GOstat web interface (http://gostat.wehi.edu.au/cgi-bin/goStat.pl) to de-
termine the most overrepresented gene ontology (GO) terms and to ob-
tain P values to indicate the significance of enrichment (see Table S1 in the
supplemental material).
Accession number. All data have been deposited into the NCBI Gene
Expression Omnibus (GEO) under accession number GSE68181.
RESULTS
RTR1 deletion causes a shift in the distribution of Ser5-P. To
capture a global picture of the distribution changes of Ser5-P
RNAPII in wild-type (WT) and rtr1 cells, we performed average
gene analysis from biological replicate ChIP-chip studies (Fig. 1A,
n 2). For illustration purposes, target genes were separated into
quartiles according to gene length, since shorter genes (such as
RPS5), show high levels of Ser5-P RNAPII occupancy across their
entire coding regions (Fig. 1A, WT 1st quartile). In the first quar-
tile that contains the shortest set of RNAPII target genes, we ob-
serve a 3= shift in Ser5-P RNAPII intensity in strains lacking Rtr1
activity (Fig. 1A, compare the 1st quartiles inWT and rtr1 cells).
A similar 3= shift in the Ser5-P intensity can be seen for each
subsequent quartile, with the 1st and 2nd quartile in rtr1 cells
displaying the highest intensity of Ser5-P at the 3= end of an aver-
age gene. In addition, we observed a higher intensity of Ser5-P
downstream of the 3= end in rtr1 cells than in WT cells. The
increase occurs in each of the four quartiles. These results, in con-
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junction with our previous findings, show that Rtr1maintains the
distribution of RNAPII Ser5-P levels in WT cells. Ser5-P levels
peak at the 5= ends of RNAPII target genes in yeast, and this mark
has been shown to play a critical role in early transcription events,
namely, mRNA capping (58). Changes in the Ser5-P distribution
throughout the genome could lead to changes in specific CTD-
interacting proteins that act as readers of the CTD code. To illus-
trate that the changes we observe in Ser5-P distribution following
deletion ofRTR1 are not caused by global changes in total RNAPII
occupancy across target genes, we have measured total RNAPII
occupancy using Rpb3-FLAG ChIP-exonuclease (exo) (Fig. 1B).
For ease of comparison, gene averaging was performed as for
the Ser5-P RNAPII data set and is shown as quartiles of gene
length (see Supplemental Methods in the supplemental mate-
rial for more details). These data clearly show that the average
total RNAPII occupancy across the genome either decreases
(quartiles 1, 2, and 3) or stays relatively unchanged (quartile 4 in
Fig. 1B). Overall, these data indicate that the increased levels of
Ser5-P RNAPII are due to decreased Ser5-P CTD dephosphoryla-
tion in rtr1 cells and not due to increases in overall RNAPII
occupancy at the 3= ends of genes.
Deletion of RTR1 causes a 3= prime shift in the distribution
of Ser5-P, which was independent of gene length (Fig. 1). To
determine the general classes of RNAPII Ser5-P distribution
changes in RTR1 deletion cells, we performed unsupervised
k-means clustering analysis of differential enrichment data
[(rtr1 IP WT IP)/input values] for annotated RNAPII tar-
get genes. We obtained five clusters from the k-means cluster-
ing, the majority of which show increased Ser5-P in the 3= end
consistent with our length analysis (Fig. 2, clusters 2, 3, and 4).
In Fig. 2A, cluster 1 genes display an increase in Ser5-P RNAPII
enrichment at the 3= ends of genes in the absence of Rtr1.
Although cluster 3 genes show a pattern similar to the pattern
of cluster 1 genes, on average, they show a higher enrichment of
Ser5-P levels in WT samples relative to data from rtr1 strains.
The average differential Ser5-P RNAPII enrichment across
cluster 4 genes is elevated in rtr1 cells than in WT cells
throughout the transcribed region (Fig. 2B), whereas the genes
in cluster 2 show Ser5-P in the rtr1 enrichment primarily at
the 3= end of the gene. Cluster 5 genes show a distinct differen-
tial enrichment pattern of Ser5-P RNAPII in rtr1 cells primar-
ily at the 5= ends of genes (Fig. 2C). We next performed GO
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term enrichment analysis and determined the top overrepre-
sented terms (P  0.01) within our clusters in order to better
understand the classes of cellular functions that are represented
by the individual gene clusters (see Table S1 in the supplemen-
tal material). Interestingly, cluster 4, in which Ser5-P RNAPII
is enriched in rtr1 cells throughout the gene body, had GO
term enrichment in genes related to ribosomal protein-coding
genes: ribonucleoprotein complex biogenesis and assembly (P
value of 1.46E0.36), rRNA metabolic process (P value of
1.31E30), and rRNA processing (P value of 5.48E30). In fact,
additional analysis of cluster 4 genes found many highly ex-
pressed genes, including PMA1, ADH1, and the ribosomal pro-
tein-coding genes.
Analysis of the role of Rtr1 in the regulation of histone
H3K36me3 levels in vivo. Once RNAPII escapes the promoter,
the CTD tail becomes phosphorylated at Ser5 and Ser2 by the
action of TFIIH and CTDK-I, respectively. The Ser2-P Ser5-P
doubly modified RNAPII CTD has been shown to recruit the his-
tone methyltransferase Set2 (45, 47). In yeast, Set2 catalyzes
mono-, di-, and trimethylation of K36 distributed over the coding
region of the gene with H3K36 trimethylation enrichment at the
3= ends of protein-coding genes (59). Set2-facilitated H3K36me3
coordinates the recruitment of the Rpd3S deacetylase complex to
the coding regions of genes. Rpd3S is responsible for the deacety-
lation of coding region histones after the passage of RNAPII to
maintain hypoacetylated chromatin architecture, which prevents
cryptic transcripts (60–62). Taken together, we hypothesize that
changes in Ser5-P distribution caused by loss of Rtr1 function will
impact H3K36me3 levels by increasing the number of Set2-CTD-
interacting sites during transcription elongation. To test our hy-
pothesis and to better understand the role of Rtr1 in regulating the
CTD binding protein Set2, we performed ChIP-chip experiments
onH3K36me3 inWT and rtr1 strains using high-density Agilent
1x244k (1 244,000) arrays with an average probe resolution of
50 nucleotides (Fig. 3). The levels of H3K36me3 throughout
RNAPII target genes was normalized by the levels of total histone
H3. Average gene enrichment analysis was performed for RNAPII
targets and separated into quartiles for transcription rate, since the
total levels of histone H3K36me3 have been shown to correlate
with RNAPII transcription rate (59, 63). The first quartile con-
tains themost rarely transcribed set of genes, and the fourth quar-
tile contains the most frequently transcribed group of genes. In
agreement with previous results, we observed increasing levels of
H3K36me3 for bothWT and rtr1 data sets from the first quartile
through the fourth quartile, showing that the total levels of
H3K36me3 correlate with transcription rate (Fig. 3A). In addi-
tion, we can see increased levels of histone H3K36me3 in rtr1
cells relative to WT cells in all four quartiles. Our analysis of total
RNAPII levels from Fig. 1B suggests that total RNAPII transcrip-
tion does not increase in rtr1 cells, although we do see dramatic
increases in Ser5-P CTD levels. The relative levels of H3K36me3
(adjusted for total histone H3 levels) are shown together for the
first and fourth quartile gene sets in Fig. 3B. These data show that
the largest differences in H3K36me3 levels occur at the 3= ends of
the RNAPII target genes. Together, these data suggest that Ser5-P
CTD dephosphorylation by rtr1 regulates H3K36me3 levels by
decreasing the number of Ser5-P Ser2-P binding sites available to
Set2 during transcription elongation.
To clearly illustrate the changes we observed in both Ser5-P
RNAPII and histone H3K36me3 levels, we have shown the pat-
terns of Ser5-P RNAPII and histone H3K36me3 across a small
region of chromosome 7 in Fig. 4. Deletion of RTR1 leads to large
increases in total RNAPII Ser5-P (normalized for total RNAPII
occupancy) across the coding region of PMA1 (Fig. 4A, left). At
the downstream gene LEU1, increased levels of Ser5-PRNAPII are
also observed at the 3= end, although the changes are smaller than
those observed at PMA1 (Fig. 4A, right). The pattern of
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FIG 2 ChIP-chip data plotted as the relative enrichment of Ser5-P (Ser5-P in
rtr1  Ser5-P in WT cells). Binned Ser5-P RNAPII ChIP-chip data were
subjected to k-means clustering, and the average differential enrichment value
[rtr1 IPWT IP)/input] for each cluster was plotted. A schematic represen-
tation of an average gene is shown at the bottom of the figure. (A) Data from
clusters 1 and 3 showing low relative RNAPII Ser5-P occupancy in the coding
region of target genes in rtr1 strains. (B) Relative Ser5-P RNAPII enrichment
in clusters 2 and 4 shows increased Ser5-P levels across the gene (cluster 4)
and/or in the 3= end of the average gene (clusters 2 and 4). (C) Increased levels
of Ser5-P RNAPII were observed in rtr1 strains at the 5= ends of cluster 5
genes.
Rtr1 Is a Global Regulator of Ser5-P RNAPII
September 2016 Volume 36 Number 17 mcb.asm.org 2239Molecular and Cellular Biology
H3K36me3 in WT Ser5-P RNAPII across the PMA1 gene is what
would be expected for a typical protein-coding gene, where the
H3K36me3 signal peaks in the coding region of the gene and be-
gins to decrease toward the 3= end just prior to the annotated
polyadenylation sites (Fig. 4B). H3K36me3 levels (normalized for
total histone H3 occupancy) increase in rtr1 cells relative to WT
cells at PMA1 (Fig. 4B, left). The largest differences in H3K36me3
levels at PMA1 are observed near the 3= end similar to the largest
differences observed in Ser5-P RNAPII levels (compare the top
and bottom representations in Fig. 5). At the downstream gene
LEU1, histoneH3K36me3 levels are also increased in rtr1 cells at
the 3= end of the gene in the same region in which increased levels
of Ser5-P RNAPII were also observed (compare the right portions
of the top and bottom representations in Fig. 5). We propose that
altered histone H3K36me3 enrichment at the 3= ends of genes
occurs as a consequence of RTR1 deletion through increased Set2
recruitment to RNAPII during transcription elongation as a con-
sequence of elevated Ser5-P CTD modification (Fig. 5).
DISCUSSION
Multiple reports have shown that deletion ofRTR1 in yeast results
in elevated Ser5-P at the 3= ends of a selection of model genes (14,
39, 52). Given that Rtr2 is an orthologue of Rtr1, it was reasonable
to assume that Rtr2may also have phosphatase activity.We tested
this hypothesis by ChIP-quantitative PCR (qPCR) on the PMA1
gene and found that RTR2 deletion does not cause significant
changes in Ser5-P RNAPII levels (see Fig. S3 in the supplemental
material). These data suggest that Rtr2 is not a primary regulator
of Ser5-P removal in vivo.We expanded our previouswork (39) by
addressing the role of Rtr1 on global levels of RNAPII phosphor-
ylation in vivo. We performed ChIP-chip experiments to measure
the changes in the Ser5-P levels in RTR1 deletion cells. Using this
approach, we clearly demonstrate that Rtr1 is a global regulator of
Ser5-P CTD modification, and Rtr1 appears to regulate Ser5-P
levels regardless of gene length and independent of total RNAPII
occupancy (Fig. 1). These findings are significant because they
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suggest that even at short genes, Rtr1 works to dephosphorylate
RNAPII during the early phases of transcription elongation. To-
gether, these findings indicate that Rtr1 is a Ser5-P CTD phospha-
tase that regulates RNAPII modification status during transcrip-
tion elongation.
Using unsupervised k-means clustering, we grouped RNAPII
target genes into five clusters based on the pattern of Ser5-P occu-
pancy changes in rtr1 cells versus WT cells. We found that most
genes, regardless of the cluster, have increased Ser5-P enrichment
at the 3= end (Fig. 2). Moreover, cluster four, in particular, dis-
played enriched Ser5-P throughout RNAPII target genes. Upon
closer inspection of this cluster, we find a high percentage of the
genes to be highly expressed yeast genes, including the prototypi-
cal yeast model genes, PMA1 and ADH1. We speculate that since
highly expressed yeast genes will by definition have higher occu-
pancy of RNAPII, this leads to a larger change in overall Ser5-P
levels in the absence of Rtr1 phosphatase activity. Our finding that
Rtr1 regulates global Ser5-P RNAPII levels at the 3= ends of genes
bears some similarity to data obtained from global analysis of
Ser7-P RNAPII levels in an Ssu72 temperature-sensitive degron
strain (Ssu72-td strain) (64). These data are intriguing, since
Ssu72 has also been implicated in the removal of Ser5-P following
cis isomerization of Pro6 in the RNAPII CTD regulated by Ess1
(65). However, Bataille et al. and Zhang et al. did not observe
significant changes in global Ser5-P levels in the Ssu72-td strain at
RNAPII target genes by ChIP-chip (18, 64). Recent work by Ro-
sado-Lugo and Hampsey suggests that specific inactivating muta-
tions in Ssu72, such as R129A and C15S, may block Rtr1 recruit-
ment to the CTD during transcription elongation, whereas the
loss of all Ssu72 protein in Ssu72-td strains allows Rtr1 to be re-
cruited normally, resulting in near wild-type levels of Ser5-P
RNAPII in the Ssu72-td strain (52). Our findings suggest that Rtr1
is a major regulator of Ser5-P RNAPII levels in vivo and that the
wild-type Ssu72 inRTR1deletion strains is not able to compensate
for Rtr1. These data suggest that Rtr1 and Ssu72may target differ-
ent populations of RNAPII for Ser5-P dephosphorylation in vivo.
By examining the effects ofRTR1 deletion on cotranscriptional
histone modifications, we were able to test the concept of a CTD
code. If precise timing of kinase-mediated CTD phosphorylation
and phosphatase-mediated CTD dephosphorylation is needed to
maintain CTD-interacting partner recruitment, loss of a CTD
phosphatase should result in altered localization or amount of
interacting partner function. In Fig. 4 and 5, it is clearly shown that
loss of the early CTD phosphatase Rtr1 results in a 3= spread of
histone H3K36me3 by Set2, a well-characterized Ser2-P Ser5-P
CTD-interacting protein and the sole H3K36me3 methyltrans-
ferase in yeast (66, 67). The changes in H3K36me3 are not caused
by changes in overall histone occupancy (Fig. 4 and 5). These data
show that Rtr1 has the greatest effect on H3K36me3 at the 3= end
of the gene, and these results directly correlate with the changeswe
observed in Ser5-P (Fig. 4). Since we observed global increases in
H3K36me3 levels rather than spread of the 3= modification in
rtr1 cells, we propose that the methyltransferase Set2 is not mis-
localized on the gene but likely remains in contact with the CTD
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for a longer period of time, thus increasing itsmodification output
(Fig. 5). These data suggest that at some genes, Set2 may stay
associated with RNAPII further downstream as a result of RTR1
deletion. This could occur as a result of Set2 mislocalization
and/or termination defects in RNAPII, resulting in increased oc-
cupancy downstream.
On the basis of our observations and previous research from
our group and others, we propose a model in which Rtr1 acts
upstream of Set2 to regulate the levels of the SRI sites along the
RNAPII CTD (Fig. 5). We have previously shown that Rtr1 re-
cruitment to RNAPII occurs in a manner that is dependent upon
the Ser2-P kinase Ctk1 (49). In fact, the increased levels of histone
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H3K36me3 in rtr1 cells is additional indirect evidence that could
suggest that Rtr1 targets Ser2-P Ser5-P modified RNAPII for de-
phosphorylation in agreement with studies on RPAP2, the human
homologue of Rtr1 (40). We propose the following model: as
polymerase enters productive elongation, Ser2-P begins to in-
crease, which leads to the recruitment of Set2 to RNAPII. Rtr1 is
recruited to the multiply phosphorylated CTD and starts to re-
move Ser5-P, which in turn will lower the affinity of Set2 for the
CTD, thereby leading to less H3K36me3 by the time RNAPII
reaches the polyadenylation site at the 3= end of the transcribed
region (Fig. 5, top). Conversely, in an rtr1 strain, Set2 retains
its high affinity for the CTD due to a lack of Ser5-P dephos-
phorylation, thus increasing the output of H3K36me3 toward
the 3= end of the gene, and perhaps in some instances, allowing
H3K36me3 to continue past its normal 3= boundary (Fig. 5,
bottom). Maintaining H3K36me3 levels is important for the
regulation of the Set2/Rpd3S pathway in yeast. This pathway is
vital for the maintenance of chromatin integrity and regulation
of cotranscriptional processes. H3K36me3 suppresses histone
exchange across the coding region (68), allowing for continu-
ous rounds of transcription and safeguarding transcriptional
memory with respect to the transcription status. Future work is
needed to determine the effects of RTR1 deletion on these
downstream pathways.
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